@article{c98aec9036314fa1a24151d99204abda,
title = "John cunningham virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals",
abstract = "We examined whether prediagnostic John Cunningham virus (JCV) antibodies and viremia are predictors of progressive multifocal leukoencephalopathy (PML) in 83 PML cases and 240 human immunodeficiency virus (HIV) disease-matched controls. JCV viremia was not predictive of PML, but some patients showed higher anti-JCV immunoglobulin G (IgG) responses 6 months prior to diagnosis.",
author = "Viscidi, {Raphael P.} and Nina Khanna and Tan, {Chen S.} and Xiuhung Li and Lisa Jacobson and Clifford, {David B.} and Avindra Nath and Margolick, {Joseph B.} and Shah, {Keerti V.} and Hirsch, {Hans H.} and Koralnik, {Igor J.}",
note = "Funding Information: Financial support. This work was sponsored in part by grants from the Neurologic AIDS Research Consortium (U01 NS322228 to D. C. and I. J. K., R01 NS 041198, NS 047029, and K24 NS 060950); Johns Hopkins NIMH Center (5P30MH075673 to A. N.); and a Biogen Idec research grant (to I. J. K.). The MACS is funded by the National Institute of Allergy and Infectious Diseases, with additional supplemental funding from the National Cancer Institute (UO1-AI-35042, 5-MO1-RR-00052 [GCRC], UO1-AI-35043, UO1-AI-35039, UO1-AI-35040, UO1-AI-35041). This study has been supported by the Swiss HIV Cohort Study and the Swiss National Science Foundation (SHCS project Nr. 512).",
year = "2011",
month = oct,
day = "1",
doi = "10.1093/cid/cir507",
language = "English",
volume = "53",
pages = "711--715",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
number = "7",
}